Use of observational data, including surveillance studies, for evaluating aids therapies

Statistics in Medicine

Volumn 15, Issue 21-22, 1996, Pages 2273-2288

  Gail, Mitchell H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOSTATISTICS; CONFERENCE PAPER; DISEASE COURSE; HUMAN; INCIDENCE; PNEUMOCYSTIS PNEUMONIA; SURVIVAL TIME; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; EVALUATION STUDIES; HUMANS; INCIDENCE; MALE; OBSERVATION; POPULATION SURVEILLANCE; UNITED STATES; ZIDOVUDINE;

EID: 0029856639     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19961115)15:21<2273::AID-SIM448>3.0.CO;2-3     Document Type: Conference Paper

References (39)

1. Finkelstein, D. M. and Schoenfeld, D. A. AIDS Clinical Trials, Wiley-Liss, 1995.
2. Hill, A. B. Principles of Medical Statistics, 9th edn, Oxford University Press, Oxford, 1971.
3. Lachin, J. M. 'Properties of simple randomization in clinical trials', Controlled Clinical Trials, 9, 312-326 (1988).
4. Byar, D. P., Simon, R. M., Friedewald, W. T., Schlesselman, J. J., DeMets, D. L., Ellenberg, J. H., Gail, M. H. and Ware, J. H. 'Randomized clinical trials': perspectives on some recent ideas', New England Journal of Medicine, 295, 74-80 (1976).
5. Miettinen, O. S. 'The need for randomization in the study of intended effects', Statistics in Medicine, 2, 267-271 (1983).
6. Byar, D. P., Green, S. B., Dor, P., Williams, E. D., Cohen, J., van Gilse, H. A., Mayer, M., Sylvester, R. J. and Van Glabbeke, M. 'A prognostic index for thyroid cancer. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group', European Journal of Cancer, 15, 1033-1041 (1979).
7. Byar, D. P. 'The necessity and justification of randomized clinical trials', in Tagnon, H. J. and Staquet, J. (eds), Controversies in Cancer, Mason, New York, 1979, pp. 75-82.
8. Byar, D. P. 'The use of data bases and historical controls in treatment comparisons', in Scheurlen, H., Kay, R. and Baum, M. (eds), Cancer Clinical Trials: A Critical Appraisal, Springer-Verlag, Berlin, 1988, pp. 95-98.
9. Piantadosi, S., Byar, D. P. and Green, S. B. 'The ecological fallacy', American Journal of Epidemiology, 127, 893-904 (1988).
10. Moore, R. D., Hidalgo, J., Sugland, B. W. and Chaisson, R. E. 'Zidovudine and the natural history of the acquired immunodeficiency syndrome', New England Journal of Medicine, 324, 1412-1416 (1991).
11. Harris, J. E. 'Improved short-term survival of AIDS patients initially diagnosed with Pneumocytis carinii pneumonia, 1984 through 1987', Journal of the American Medical Association, 263, 397-401 (1990).
12. Centers for Disease Control. 'Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome', Morbidity and Mortality Weekly Report, 36 (suppl 1), 1-15 (1987).
13. Lemp, G. L., Payne, S. F., Neal, D., Temelso, T. and Rutherford, G. W. 'Survival trends for patients with AIDS', Journal of the American Medical Association, 263, 402-406 (1990).
14. Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., Jackson, G. G., Durack, D. T., King, D. and the AZT Collaborative Working Group. 'The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind placebo-controlled trial', New England Journal of Medicine, 317, 185-191 (1987).
15. Leoung, G. S., Feigal, D. W., Montgomery, A. B., Corkery, K., Wardlaw, L., Adams, M., Busch, D., Gordon, S., Jacobson, M. A., Volberding, P. A., Abrams, D. and the San Francisco County Community Consortium. 'Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco Community Prophylaxis Trial', New England Journal of Medicine, 323, 769-775 (1990).
16. Gail, M. H., Pluda, J. M., Rabkin, C. S., Biggar, R. J., Goedert, J. J., Horm, J. W., Sondik, E. J., Yarchoan, R. and Broder, S. 'Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome', Journal of the National Cancer Institute, 83, 695-701 (1991).
17. Brookmeyer, R. and Liao, J. 'The analysis of delays in disease reporting: methods and results for the acquired immunodeficiency syndrome', American Journal of Epidemiology, 132, 355-365 (1990).
18. Fätkenheuer, G., Stützer, H., Salzberger, B. and Schrappe, M. 'Zidovudine and the natural history of AIDS (letter)', New England Journal of Medicine, 325, 1311-1312 (1991).
19. Centers for Disease Control. 'HIV/AIDS Surveillance Report', January, 1992, pp. 1-22.
20. Brookmeyer, R. and Gail, M. H. AIDS Epidemiology: A Quantitative Approach, Oxford University Press, Oxford, 1994.
21. Selik, R. M., Beuhler, J. W., Karon, J. M., Chamberland, M. E. and Berkelman, R. L. 'Impact of the 1987 revision of the case definition of AIDS in the United States', Journal of Acquired Immune Deficiency Syndromes, 3, 73-82 (1990).
22. Morgan, W. M. and Curran, J. W. 'Acquird immunodeficiency syndrome: current and future trends', Public Health Reports, 101, 459-465 (1986).
23. Brookmeyer, R. and Gail, M. H. 'Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States', Lancet, 2, 1320-1322 (1986).
24. Brookmeyer, R. and Gail, M. H. 'A method for obtaining short-term projections and lower bounds on the size of the AIDS epidemic', Journal of the American Statistical Association, 83, 301-308 (1988).
25. Rosenberg, P. S., Gail, M. H. and Pee, D. 'Mean square error of estimates of HIV prevalence and short-term AIDS projections derived by backcalculation', Statistics in Medicine, 10, 1167-1180 (1991).
26. Gail, M. H., Rosenberg, P. S. and Goedert J. J. 'Therapy may explain recent deficits in AIDS incidence', Journal of Acquired Immune Deficiency Syndromes, 3, 296-306 (1990).
27. Bacchetti, P., Segal, M. and Jewell, N. P. 'Uncertainty about the incubation period of AIDS and its impact on backcalculation', in Jewell, N., Dietz, K. and Farewell, V. (eds), AIDS Epidemiology: Methodologic Issues, Birkhäuser- Boston, Boston, 1992, pp. 61-80.
28. Gail, M. H. and Rosenberg, P. S. 'Perspectives on using backcalculation to estimate HIV prevalence and project AIDS incidence', in Jewell, N., Dietz, K. and Farewell, V. (eds), AIDS Epidemiology: Methodologic Issues, Birkhäuser-Boston, Boston, 1992, pp. 1-38.
29. Buehler, J. W., Berkelman R. L. and Stehr-Green, J. K. 'The completeness of AIDS surveillance', Journal of Acquired Immune Deficiency Syndromes, 5, 257-264 (1992).
30. 3', New England Journal of Medicine, 322, 941-949 (1990).
31. Fischl, M. A., Richman, D. D., Hansen, N., Collier, A. C., Carey, J. T., Para, M. F., Hardy, D., Dolin, R., Powderly, W. G., Allan, J. D., Wong, B., Merigan, T. C., McAuliffe, V. J., Hyslop, N. E., Rhame, F. S., Balfour, H. H., Spector, S. A., Volberding, P., Pettinelli, C., Anderson, J. and the AIDS Clinical Trials Group. 'The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind placebo-controlled trial', Annals of Internal Medicine, 112, 727-737 (1990).
32. Hamilton, J. D., Hartigan, P. M., Simberkoff, M. S., Day, P. L., Diamond, G. R., Dickinson, G. M., Drusano, G. L., Egorin, M. J., George, W. L., Gordin, F. M., Hawkes, C. A., Jensen, P. C., Klimas, N. G., Labriola, A. M., Lahart, C. J., O'Brien, W. A., Oster, C. N., Weinhold, K. J., Wray, N. P., Zolla-Pazner, S. B. and the Veterans Affairs Cooperative Study Group on AIDS Treatment 'A controlled trial of early versus late treatment with zidovudine in human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study', New England Journal of Medicine, 326, 437-443 (1992).
33. Rosenberg, P. S., Gail, M. H., Schrager, L. K., Vermund, S. H., Creagh-Kirk, T., Andrews, E. B., Winkelstein, W. Jr, Marmor, M., Des Jarlais, D. C., Biggar, R. J. and Goedert, J. J. 'National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups', Journal of Acquired Immune Deficiency Syndromes, 4, 392-401 (1991).
34. Graham, N. M. H., Zeger, S. L., Kuo, V., Jacobson, L. P., Vermund, S. H., Phair, J. P., Detels, R., Rinoldo, C. R., Saah, A. J., and the Multicenter AIDS Cohort Study. 'Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989', Journal of Acquired Immune Deficiency Syndromes, 4, 267-276 (1991).
35. Lang, W., Osmond, D., Samuel, M., Moss, A., Schrager, L. and Winkelstein, W. Jr. 'Population-based estimates of zidovudine and aerosol pentamidine use in San Francisco: 1987-1989', Journal of Acquired Immune Deficiency Syndromes, 4, 713-716 (1991).
36. Fife, D. and Mode, C. 'AIDS incidence and income', Journal of Acquired Immune Deficiency Syndromes, 5, 1105-1110 (1992).
37. Brookmeyer, R. 'Reconstruction and future trends of the AIDS epidemic in the United States', Science, 253, 37-42 (1991).
38. Rosenberg, P. S., Gail, M. H. and Carroll, R. J. 'Estimating HIV prevalence and projecting AIDS incidence in the United States: a model that accounts for therapy and changes in the surveillance definition of AIDS', Statistics in Medicine, 11, 1633-1655 (1992).
39. Centers for Disease Control. 'Projections of the number of persons diagnosed with AIDS and number of immunosuppressed HIV-infected persons-United States, 1992-1994', Morbidity and Mortality Weekly Report, 41, 1-29 (1992).